Top Trader: Can Someone Explain To Me Like I’m 3 Why XRP Isn’t Over $100 Already?
Ripple continues to expand its presence across the financial sector, yet XRP has not reached the valuations some investors expect from that growth.
His question focuses on the relationship between Ripple’s institutional expansion and XRP’s market value. Several responses to the post challenged the idea that new bank partnerships alone can drive XRP toward significantly higher prices.
XRP Usage Could Matter More Than Ripple Partnerships
DM Benders explained that XRP needs actual usage to generate the demand that could support a much higher valuation. He said banks have not yet created enough direct XRP usage to justify the expectations surrounding the asset.
“It’s not being used yet. What’s wrong with you folks? It’s pretty simple. XRP is not going to move when you want it to based on news. It’s going to move based on its usage/utility,” DM Benders wrote.
His comment separates Ripple’s business development from XRP’s market demand. Ripple can add financial institutions to its network without those institutions creating significant demand for XRP.
The distinction matters because a bank can use Ripple’s technology without holding XRP for an extended period. Investors therefore need to look at the level of XRP usage alongside Ripple’s growing institutional relationships.
Commenters Point To XRP Utilization And Supply
Andrew Sandler raised several factors that could explain XRP’s current valuation. He mentioned regulatory clarity and Ripple’s monthly escrow activity, noting that the company’s regular escrow releases could limit XRP’s price growth.
Banks May Not Hold XRP Long Term
Rara also challenged the assumption that more bank partnerships automatically create massive XRP demand.
“Banks using RippleNet’s ODL service doesn’t mean they’re gonna stockpile XRP,” Rara said.
The comment points to XRP’s role during transactions. If institutions acquire XRP to facilitate transfers and then quickly exchange it for another currency, that activity can create transaction volume without creating the same long-term holding demand that some XRP investors expect.
Steph Is Crypto’s question therefore centers on an important distinction. Ripple can continue expanding its banking partnerships while XRP follows its own demand dynamics. The asset’s path toward much higher valuations will depend on how extensively institutions use XRP and how that usage affects sustained market demand.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Reports of iPhone production cuts send Apple shares lower
October 9 – According to Nikkei Asia (link), Apple has asked its suppliers to cut production of the new iPhone 18 Pro model due to weak demand, resulting in Apple (AAPL.O) shares falling 1.8% in premarket trading to $334.21. The report states that, against the backdrop of soaring memory chip costs and rising prices, the component orders for October have been reduced by at least 15% compared to initial requirements. Apple has not yet responded to a Reuters request for comment. The current stock price is about 1% lower than the all-time intraday high of $345.34 reached on September 22. According to data compiled by the London Stock Exchange Group (LSEG), the average rating from 43 analysts covering the stock is "Buy," with a median target price of $330. (For the convenience of non-English speakers, Reuters provides automated translations of its report into several other languages. As automated translations may contain errors or lack the required context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for reader convenience. Reuters accepts no liability for any damage or loss resulting from use of the automated translation function.)
Citi maintains a “Neutral” rating on DocuSign (DOCU.O): IAM platform migration shows initial effectiveness, double-digit growth still needs "validation"
Citi published a research report maintaining a "Neutral" rating on the e-signature and agreement cloud platform DocuSign, with a target price of $72.
Humana shares soar as it becomes the biggest beneficiary of the 2027 Medicare star ratings.
Reuters, October 9 – In pre-market trading on Friday, shares of Humana (stock code: HUM.N) rose by 15%. Analysts said the health insurer is set to be the biggest beneficiary of the new 2027 Medicare Advantage star ratings. Humana stated that, with improvements in healthcare quality and member experience indicators, 95% of its Medicare Advantage members will be enrolled in plans rated four stars or higher by 2027, a substantial jump from 20% in 2026 (link). JPMorgan analysts noted that they had previously projected this ratio to be between 60% and 70%. The U.S. Department of Health and Human Services uses a one- to five-star scale to rate Medicare Advantage and prescription drug plans. Higher ratings lead to government bonuses worth billions of dollars and can help attract more members. Analysts noted that Humana’s ratings performance outpaced its larger competitors: JPMorgan expects the proportion of UnitedHealth Group’s (UNH.N) plans rated four stars or higher to decrease from 81% to about 67%, while CVS Health’s (CVS.N) ratio will fall from 84% to about 70%. The U.S. Department of Health and Human Services said Thursday night that, overall, about 71% (link) of Medicare Advantage prescription drug plan enrollees will be in contracts rated four stars or higher in 2027. Evercore ISI analyst Elizabeth Anderson said that Humana had improved in prescription drug plan quality, health plan quality, and readmission rates. She added, “This improvement reflects management’s increased focus on these metrics over the past year.” Health insurers provide Medicare Advantage plans for the government to adults aged 65 and older and people with disabilities.
Illia Polosukhin: NEAR accounts can achieve quantum resistance through key updates
Crypto prices
More
